Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deliberate Attenuation of Chikungunya Virus by Adaptation to Heparan Sulfate-Dependent Infectivity: A Model for Rational Arboviral Vaccine Design
Authors
Keywords
-
Journal
PLoS Neglected Tropical Diseases
Volume 8, Issue 2, Pages e2719
Publisher
Public Library of Science (PLoS)
Online
2014-02-21
DOI
10.1371/journal.pntd.0002719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy
- (2013) Simon-Djamel Thiberville et al. ANTIVIRAL RESEARCH
- An Essential Role of Antibodies in the Control of Chikungunya Virus Infection
- (2013) F.-M. Lum et al. JOURNAL OF IMMUNOLOGY
- Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
- (2013) Haiyan Chu et al. VACCINE
- Microbial heparin/heparan sulphate lyases: potential and applications
- (2012) C. K. M. Tripathi et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Chikungunya virus and prospects for a vaccine
- (2012) Scott C Weaver et al. Expert Review of Vaccines
- DrosophilaHeparan Sulfate, a Novel Design
- (2012) Marion Kusche-Gullberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice
- (2012) T.-H. Teo et al. JOURNAL OF IMMUNOLOGY
- Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein
- (2012) R. Gorchakov et al. JOURNAL OF VIROLOGY
- US Military contributions to the global response to pandemic chikungunya
- (2012) Charles H. Hoke et al. VACCINE
- Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate
- (2012) Christina L. Gardner et al. VIROLOGY
- The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry
- (2012) Hans Henrik Gad et al. VIROLOGY
- Modeling Dynamic Introduction of Chikungunya Virus in the United States
- (2012) Diego Ruiz-Moreno et al. PLoS Neglected Tropical Diseases
- A Mouse Model of Chikungunya Virus–Induced Musculoskeletal Inflammatory Disease
- (2011) Thomas E. Morrison et al. AMERICAN JOURNAL OF PATHOLOGY
- Genomic evolution and phenotypic distinctions of Chikungunya viruses causing the Indian Ocean outbreak
- (2011) Ann M Powers EXPERIMENTAL BIOLOGY AND MEDICINE
- Protection From Arthritis and Myositis in a Mouse Model of Acute Chikungunya Virus Disease by Bindarit, an Inhibitor of Monocyte Chemotactic Protein-1 Synthesis
- (2011) Nestor E. Rulli et al. JOURNAL OF INFECTIOUS DISEASES
- Chikungunya: a re-emerging virus
- (2011) Felicity J Burt et al. LANCET
- Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence
- (2011) C. L. Gardner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling
- (2011) Charalambos D. Partidos et al. VACCINE
- Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity
- (2011) Alyson A. Kelvin et al. PLoS Neglected Tropical Diseases
- Yellow Fever: A Reemerging Threat
- (2010) Christina L. Gardner et al. CLINICS IN LABORATORY MEDICINE
- Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development
- (2010) L. Darryl Quarles et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response
- (2010) J. J. Hoarau et al. JOURNAL OF IMMUNOLOGY
- The Acute Phase of Chikungunya Virus Infection in Humans Is Associated With Strong Innate Immunity and T CD8 Cell Activation
- (2010) Nadia Wauquier et al. JOURNAL OF INFECTIOUS DISEASES
- Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor
- (2010) Angela Chow et al. JOURNAL OF INFECTIOUS DISEASES
- Chikungunya Virus Arthritis in Adult Wild-Type Mice
- (2010) J. Gardner et al. JOURNAL OF VIROLOGY
- Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
- (2010) James E. Voss et al. NATURE
- Mosquito-Borne Illnesses in Travelers: A Review of Risk and Prevention
- (2010) Edith Mirzaian et al. PHARMACOTHERAPY
- Endocytosis of Chikungunya Virus into Mammalian Cells: Role of Clathrin and Early Endosomal Compartments
- (2010) Eric Bernard et al. PLoS One
- A structural and functional perspective of alphavirus replication and assembly
- (2009) Joyce Jose et al. Future Microbiology
- IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
- (2009) Lisa F. P. Ng et al. PLoS One
- Yellow fever vaccine: past, present and future
- (2008) Anna H Roukens et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence
- (2008) E. Lee et al. JOURNAL OF VIROLOGY
- Chimeric alphavirus vaccine candidates for chikungunya
- (2008) Eryu Wang et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started